CorePlus and Ibex show real world success with AI for routine cancer diagnosis.
CorePlus and Ibex show real world success with AI for routine cancer diagnosis
Published on January 5, 2024Publications
Unprecedented Patient Care: CorePlus Uses AI for 100% QC in Cervical Cytology
Insights into the shift from manual microscopy to digital diagnostics using Techcyte's AI platform.VideosHealth Industry Summit 2024 by the Puerto Rico Manufacturers Association
Mariano de Socarraz, founder and CEO of CorePlus, during the Health Industry Summit 2024 of the Puerto Rico Manufacturers Association.…EventsArteraAI Announces Research Agreement with CorePlus
ArteraAI, a developer of AI-based cancer tests, has partnered with CorePlus, a CLIA-certified pathology laboratory in Puerto Rico.Publications